Mid-Day Market Update: Allergan Jumps On Acquisition News; Conatus Pharmaceuticals Shares Plunge

Midway through trading Tuesday, the Dow traded down 0.38% to 26624.77 while the NASDAQ fell 0.95% to 7,929.49. The S&P also fell, dropping 0.55% to 2,929.04.

Leading and Lagging Sectors

Health care shares slipped by just 0.08% on Tuesday. Meanwhile, top gainers in the sector included Allergan plc AGN, up 26%, and Xencor, Inc. XNCR, up 13%.

In trading on Tuesday, communication services shares fell 1.3%.


Top Headline

Lennar Corporation LEN announced better-than-expected results for its second quarter.

Lennar reported second-quarter earnings of $1.30 per share, which beat the analyst consensus estimate of $1.14. The company reported quarterly sales of $5.6 billion, which beat the analyst consensus estimate of $5.1 billion.



Equities Trading UP

Pyxus International, Inc. PYX shares shot up 27% to $17.05 after Imperial Capital initiated coverage on the stock with an Outperform rating and announced a $71 price target.

Shares of Allergan plc AGN got a boost, shooting up 27% to $164.05. AbbVie Inc ABBV reached a deal to acquire Allergan for $63 billion. Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share, for a total of $188.24 per Allergan share.

Rafael Holdings, Inc. RFL shares were also up, gaining 16% to $27.76. Rafael Pharmaceuticals entered into an out-licensing agreement with Ono Pharmaceutical to accelerate clinical development and commercialization of cancer drug candidate CPI-613 in Japan and other Asian countries.
.


Equities Trading DOWN

Acer Therapeutics Inc. ACER shares tumbled 78% to $4.33 after the FDA rejected its New Drug Application for EDSIVO.

Shares of Conatus Pharmaceuticals Inc. CNAT were down 64% to $0.3280 after the company announced its ENCORE-LF trial of Emricasan did not meet its primary endpoint. The company will discontinue treatment, reduce its workforce and pursue strategic alternatives.

Gamida Cell Ltd. GMDA was down, falling 27% to $5.29. Gamida Cell announced the launch of a proposed follow-on public offering of about $30 million worth of its shares.

Commodities

In commodity news, oil traded up 0.2% to $58.03, while gold traded up 0.7% to $1,428.30.

Silver traded up 0.1% Tuesday to $15.39, while copper rose 1.2% to $2.7375.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.1%, the Spanish Ibex Index fell 0.36%, while Italy’s FTSE MIB Index dropped 0.73%. Meanwhile, the German DAX slipped 0.38%, and the French CAC 40 fell 0.13% while UK shares rose 0.08%.

Economics

The Johnson Redbook Retail Sales Index fell 2.5% during the first three weeks of June versus May.

The S&P Corelogic Case-Shiller home price index increased 2.5% year-over-year in April, versus a revised 2.6 percent rise in the prior month.

The FHFA's house price index rose 0.4% in April, compared to a 0.1% increase in the prior month.

New home sales fell 7.8% for May to an annual rate of 626,000 in May.

The Conference Board consumer confidence index fell to 121.5 for June, versus a revised reading of 131.3.

The Richmond Fed's manufacturing index fell to 3 for June, versus prior reading of 5.

St. Louis Federal Reserve Bank President James Bullard will speak in St. Louis, Missouri at 6:30 p.m. ET.

Posted In: NewsEurozoneCommoditiesGlobalIntraday UpdateMarketsConsumer DiscretionaryHomebuildingMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...